EUVIMEDEUVIMED entdecken
Crossref

Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain

Yu Wang, Xinzhen Fu, Meihua Zheng, Qian Liu, Hailin Gan, Zeyu Song, Mingyan Yang, Ke Liu, Zeping Xie, Huaying Fan iD

European Journal of Pain · 2024

DOI: 10.1002/ejp.2300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pain, 2024. Verfasst von Yu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: Cannabidiol, Neuralgia, Nanoparticles, Analgesics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The current analgesics often prevent patients from getting effective treatment due to their adverse effects. Cannabidiol (CBD) is well tolerated, has few side effects and has been extensively investigated in analgesia. However, its oral bioavailability is extremely low. In order to solve this problem, we developed the cannabidiol nanocrystals (CBD‐NC) in the earlier stage.

Methods

In this study, we evaluated the nociceptive behaviours associated with neuropathic pain (NP) induced by the spared nerve injury (SNI) model. Assessment of pain threshold was evaluated by paw withdraw threshold (PWT) and paw withdrawal latency (PWL). The improving effect on the motor dysfunction was determined by rota‐rod testing. To assess the neuroprotective effect, nerve demyelination and expression of peripheral myelin protein PMP22 were measured with myelin sheath staining and western blotting. Protein expressions in microglia of spinal cord were tested by western blot to explore the underlying mechanism.

Results

Compared with the CBD oil solution, CBD‐NC significantly reduced mechanical allodynia and thermal hyperalgesia in rats. CBD‐NC could improve motor dysfunction induced by SNI in rats, significantly reverse the demyelination and increase the expression of the marker protein of peripheral myelin. Underlying spinal analgesic mechanism of microglia and related factors were preliminarily confirmed.

Conclusions

CBD‐NC administration is an effective treatment for NP associated with SNI, and the analgesic effect of CBD‐NC was significantly better than that of CBD oil sol. By contrast, CBD‐NC has a fast‐acting and long‐term effect in the treatment of NP. Our study further supports the potential therapeutic effect of CBD‐NC on NP. Significance The absolute bioavailability of the CBD‐NC intramuscular injection formulation can reach 203.31%, which can solve the problem of low oral bioavailability. This research evaluated the therapeutic effect of CBD‐NC on NP associated with the SNI model for the first time. All available date showed that whatever the analgesic or neuroprotective effect of CBD‐NC, it was significantly better than that of CBD oil sol., which was consistent with the results of the pharmacokinetic. This research supports the initiation of more trials testing the efficacy of CBD‐NC for treating NP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolNeuralgiaNanoparticlesAnalgesicsRats, Sprague-DawleyAnimalsMaleRatsHyperalgesiaDisease Models, AnimalPain ThresholdPowders

Substanzen

CannabidiolAnalgesicsPowders

Autor:innen und Institutionen

  • School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…
  • School of Pharmacy, Binzhou Medical University, Yantai, China.
  • Shandong Boyuan Biomedical Co., Ltd, Yantai, China.

ORCID-Profile: Huaying Fan

Zitieren

APA

Wang, Y., Fu, X., Zheng, M., Liu, Q., Gan, H., Song, Z., Yang, M., Liu, K., Xie, Z., & Fan, H. (2024). Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain. European Journal of Pain. https://doi.org/10.1002/ejp.2300

Vancouver

Wang Y, Fu X, Zheng M, Liu Q, Gan H, Song Z, et al. Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain. European Journal of Pain. 2024. doi:10.1002/ejp.2300

BibTeX
@article{Wang2024,
  author = {Wang, Yu and Fu, Xinzhen and Zheng, Meihua and Liu, Qian and Gan, Hailin and Song, Zeyu and Yang, Mingyan and Liu, Ke and Xie, Zeping and Fan, Huaying},
  title = {Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain},
  journal = {European Journal of Pain},
  year = {2024},
  doi = {10.1002/ejp.2300}
}
Kostenlos starten →